Virtual Mission May 2021

The virtual Mission took place on 10-12 May 2021. The program offered a thematic approach: 

  • 10 May: Microbial Diagnostics
  • 11 May: Antimicrobials and antimicrobial treatments
  • 12 May: Preventives (& vaccines) and stewardship tools

Event hashtag: #AMRMissionUK  

Program (BST; UK time

10 MAY: MICROBIAL DIAGNOSTICS
Chairperson: Dr Peter Dirken; Innovate UK

01:00 – 01:15 pm

Welcome by Dr Ruth McKernan; Neuroscientist, businesswoman and innovation leader.

01:15 – 01:45 pm

Impact of microbial diagnostics on the curbing of AMR in a UK perspective. 
Prof Till Bachmann; University of Edinburgh and Thematic Champion Diagnostics (UK)

01:45 – 02:15 pm

Diagnostic innovation to combat AMR: pains and pearls from an industry viewpoint.
Dr Mark Miller; Executive VP; Chief Medical Officer, bioMérieux (F)

02:15 – 02:30 pm

How to fund innovation and global collaboration
Jo Frost; Innovate UK (UK)

02:30 – 02:45 pm

How NIHR can boost collaboration in the UK
Dr Mimoza Hoti; National Institute for Health Research (UK)

02:45 – 03:00 pm

Q&A

03:00 – 06:00 pm


Partnering Program
Due to the unexpectedly high interest in the partnering sessions, it was decided to hold the informal networking during the physical mission later this year.

11 MAY: ANTIMICROBIALS
Chairperson: Dr Phil Packer; Innovate UK

01:00 – 01:15 pm

Welcome 

01:15 – 01:45 pm

Small But Crucial – The Role of Biotech in Innovating Antibiotic R&D 
Dr David Powell; CSO Summit Therapeutics and Thematic Champion Antimicrobials (UK)

01:45 – 02:15 pm

 

The future of AMR reimbursement: What types of products will succeed?
Dr John Rex; Chief Medical Officer, F2G Ltd. (USA), Editor-in-Chief, AMR Solutions, Operating Partner, Advent Life Sciences Adjunct Professor of Medicine, McGovern Medical School, Houston, Texas, USA

02:15 – 02:30 pm

How to fund innovation and global collaboration
Jo Frost; Innovate UK (UK)

02:30 – 02:45 pm

The Human Microbiome and its defensive actions against AMR
Prof Julian Marchesi; Imperial College London (UK)

02:45 – 03:00 pm

Q&A

03:00 – 06:00 pm


Partnering Program
Due to the unexpectedly high interest in the partnering sessions, it was decided to hold the informal networking during the physical mission later this year.

12 MAY: PREVENTION & STEWARDSHIP
Chairperson: Dr Maarten B.M. van Dongen; AMR Insights

01:00 – 01:15 pm

Welcome by Santiago Gonzalez; Senior Policy Advisor to Senator Michael Bennet, Colorado (USA)

01:15 – 01:45 pm

Potential impact of vaccination on curbing AMR from a UK and global perspective
Prof Cal MacLennan, Bacterial Vaccines, Global Health – Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation; Senior Clinical Fellow & Jenner Investigator, Jenner Institute, University of Oxford; Professor of Vaccine Immunology & Director of BactiVac Bacterial Vaccines Network, University of Birmingham

01:45 – 02:15 pm

Innovation and global collaboration iiCON:  developing infectious disease therapeutics. 
Prof Janet Hemingway; Director Liverpool School of Tropical Medicine (LSTM; UK)

02:15 – 02:30 pm

How to fund innovation and global collaboration
Jo Frost; Innovate UK (UK)

02:30 – 02:45 pm

Development, evaluation, and deployment of diagnostic tests for precision antimicrobial prescribing 
Dr Philip Turner, NIHR Community Healthcare MedTech and IVD Co-operative, University of Oxford (UK)

02:45 – 03:00 pm

Q&A

03:00 – 03:15 pm 

Closure of the Virtual Mission & look ahead to the Physical Mission in October

03:00 – 06:00 pm


Partnering Program
Due to the unexpectedly high interest in the partnering sessions, it was decided to hold the informal networking during the physical mission later this year.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!